Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
Med15 function in pancreatic beta cells
EF 2020-21
Résumé
When the insulin secreting ß-cells of the pancreas are unable to secrete enough insulin to maintain normal blood sugar (glucose) levels, type 2 diabetes (T2D) develops. Making insulin secreting ß-cells in the lab for transplantation is a promising therapy for T2D, but we need more knowledge of ß-cell function and maturation to do this. Transcription factors (TFs), are important proteins for ß-cell maturation and interact with coregulators such as the Mediator complex. Mediator subunit 15 (MED15) has a role in glucose and lipid metabolism in worms and in human cells. Previous data from our lab show that mice without Med15 (aka Med15 knockouts) at an early age have dysfunctional ß-cell maturation and insulin secretion. However, we do not know if Med15 is also required to maintain a matured state in adult mice. I hypothesize that Med15 is consistently required to maintain maturity of pancreatic ß-cells. Using mouse models, I will knockout Med15 after ß-cells are fully matured, to test if Med15 is required in already mature ß-cells. I will then test if insulin secretion in response to glucose levels is affected by the loss of Med15. Expression of maturity markers in the pancreas will be measured. To examine how Med15 helps the ß-cells cope with molecular stress, I will place mice on a high fat diet (HFD), which is similar to the processed food diet of the Western world, to induce T2D, and then undergo similar assessments. These experiments will reveal if Med15 is required to maintain functionally mature ß-cells, and if Med15 could be used to defend ß-cells against HFD-induced stress. Both are important insights for the successful in vitro generation of pancreatic ß-cells, which will produce a much-needed supply of human insulin-secreting cells for T2D patients.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
449705
Name
Spencer Rachel
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Med15 function in pancreatic beta cells
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Beta Cells; Diabetes; Gene Regulation; Genetics; Mutation; Physiology; Transcription
Abstract
When the insulin secreting ß-cells of the pancreas are unable to secrete enough insulin to maintain normal blood sugar (glucose) levels, type 2 diabetes (T2D) develops. Making insulin secreting ß-cells in the lab for transplantation is a promising therapy for T2D, but we need more knowledge of ß-cell function and maturation to do this. Transcription factors (TFs), are important proteins for ß-cell maturation and interact with coregulators such as the Mediator complex. Mediator subunit 15 (MED15) has a role in glucose and lipid metabolism in worms and in human cells. Previous data from our lab show that mice without Med15 (aka Med15 knockouts) at an early age have dysfunctional ß-cell maturation and insulin secretion. However, we do not know if Med15 is also required to maintain a matured state in adult mice. I hypothesize that Med15 is consistently required to maintain maturity of pancreatic ß-cells. Using mouse models, I will knockout Med15 after ß-cells are fully matured, to test if Med15 is required in already mature ß-cells. I will then test if insulin secretion in response to glucose levels is affected by the loss of Med15. Expression of maturity markers in the pancreas will be measured. To examine how Med15 helps the ß-cells cope with molecular stress, I will place mice on a high fat diet (HFD), which is similar to the processed food diet of the Western world, to induce T2D, and then undergo similar assessments. These experiments will reveal if Med15 is required to maintain functionally mature ß-cells, and if Med15 could be used to defend ß-cells against HFD-induced stress. Both are important insights for the successful in vitro generation of pancreatic ß-cells, which will produce a much-needed supply of human insulin-secreting cells for T2D patients.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Spencer, Rachel
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~